Stock Trading History of Kelley Kenneth J

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kelley Kenneth J since year 2005. The trader's CIK number is 1291219. At the time of this reporting, Kelley Kenneth J is the Director of Halozyme Therapeutics Inc (stock ticker symbol HTI).

Stock purchases, sales, and option exercises reported by *Kelley Kenneth J* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-05-25	HALO	Halozyme Therapeutics Inc	Option Exercise	22,500	3.45	77,625
2007-05-25	HALO	Halozyme Therapeutics Inc	Sale	22,500	10.27	231,065
2007-05-18	HALO	Halozyme Therapeutics Inc	Sale	15,000	10.56	158,329
2007-05-07	HTI	Halozyme Therapeutics Inc	Option Exercise	12,500	4.10	51,249
2007-05-07	HTI	Halozyme Therapeutics Inc	Sale	12,500	10.42	130,240
2007-04-30	HTI	Halozyme Therapeutics Inc	Sale	25,000	10.32	258,093
2007-04-30	HTI	Halozyme Therapeutics Inc	Option Exercise	25,000	4.10	102,499
2007-04-23	HTI	Halozyme Therapeutics Inc	Option Exercise	25,000	4.10	102,499
2007-04-23	HTI	Halozyme Therapeutics Inc	Sale	25,000	8.89	222,305
2007-04-16	HTI	Halozyme Therapeutics Inc	Option Exercise	25,000	4.10	102,499
2007-04-16	HTI	Halozyme Therapeutics Inc	Sale	25,000	9.07	226,714
2007-04-09	HTI	Halozyme Therapeutics Inc	Option Exercise	25,000	4.10	102,499
2007-04-09	HTI	Halozyme Therapeutics Inc	Sale	25,000	8.46	211,625
2007-04-02	HTI	Halozyme Therapeutics Inc	Sale	25,000	8.06	201,395
2007-04-02	HTI	Halozyme Therapeutics Inc	Option Exercise	25,000	4.10	102,499
2007-03-27	HTI	Halozyme Therapeutics Inc	Sale	500	8.39	4,196
2007-03-27	HTI	Halozyme Therapeutics Inc	Sale	8,238	8.32	68,498
2007-03-26	HTI	Halozyme Therapeutics Inc	Sale	16,262	8.43	137,096
2007-03-26	HTI	Halozyme Therapeutics Inc	Option Exercise	25,000	2.05	51,249
2007-03-19	HTI	Halozyme Therapeutics Inc	Option Exercise	25,000	2.05	51,249
2007-03-19	HTI	Halozyme Therapeutics Inc	Sale	25,000	8.71	217,703
2007-03-14	HTI	Halozyme Therapeutics Inc	Option Exercise	25,000	2.05	51,249
2007-03-14	HTI	Halozyme Therapeutics Inc	Sale	25,000	7.92	197,906

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kelley Kenneth J (Director of Halozyme Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.